{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:37:28Z","timestamp":1726101448209},"reference-count":48,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":7899,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. j. neurol. sci."],"published-print":{"date-parts":[[1994,2]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title><jats:p>Gilles de la Tourette syndrome is a neurological disorder characterized by the presence of motor and vocal tics. Other associated features include complex motor and vocal tics, obsessive compulsive behavior and attention-deficit disorder. Although initially thought to be a rare condition, it now appears that the gene for Tourette syndrome may be present in as many as one in a thousand people, and is transmitted as an autosomal dominant trait. However, many individuals carrying the gene may exhibit only minimal symptoms. Neuropathophysiology of Tourette syndrome is unknown but investigations have suggested that the cause may be an abnormality either in the dopaminergic or endorphin receptor system within the basal ganglia. Treatment of Tourette syndrome involves education and counseling of the patient and family. Medications such as neuroleptics, serotonin-reuptake inhibitors, and stimulants are available to treat the manifestations of Tourette syndrome and need to be individualized for each patient.<\/jats:p>","DOI":"10.1017\/s0317167100048769","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T04:12:27Z","timestamp":1455682347000},"page":"48-52","source":"Crossref","is-referenced-by-count":12,"title":["Gilles de la Tourette Syndrome \u2013 Review Article"],"prefix":"10.1017","volume":"21","author":[{"given":"O.","family":"Suchowersky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"S0317167100048769_ref020","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520350038012"},{"key":"S0317167100048769_ref011","first-page":"822","article-title":"A controlled study of Tourette syndrome. VI Early development, sleep problems, allergies and handedness","volume":"41","author":"Comings","year":"1987","journal-title":"Am J Hum Genet"},{"key":"S0317167100048769_ref025","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.4.592"},{"key":"S0317167100048769_ref030","doi-asserted-by":"publisher","DOI":"10.1097\/00004703-198408000-00008"},{"key":"S0317167100048769_ref003","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.2.147"},{"key":"S0317167100048769_ref044","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.9.1346"},{"key":"S0317167100048769_ref032","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410120408"},{"key":"S0317167100048769_ref023","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.3.472"},{"key":"S0317167100048769_ref028","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1983.04050070073019"},{"key":"S0317167100048769_ref009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198610163151604"},{"key":"S0317167100048769_ref024","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.4.784"},{"key":"S0317167100048769_ref048","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.6.872"},{"key":"S0317167100048769_ref034","first-page":"227","article-title":"PET studies on integrity of the pre- and post-synaptic dopaminergic system in Tourette\u2019s Syndrome","volume":"58","author":"Brook","year":"1991","journal-title":"Adv Neurol"},{"key":"S0317167100048769_ref033","first-page":"135","volume":"58","author":"Singer","year":"1992","journal-title":"Neurochemical analysis of post-mortem cortical and striatal brain tissue in patients with Tourette\u2019s syndrome"},{"key":"S0317167100048769_ref001","volume-title":"Gilles de la Tourette syndrome","author":"Shapiro","year":"1988"},{"key":"S0317167100048769_ref002","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.12.1625"},{"key":"S0317167100048769_ref004","first-page":"435","article-title":"Tourette syndrome: clinical and psychological aspects of 250 cases","volume":"37","author":"Comings","year":"1985","journal-title":"Am J Hum Genet"},{"key":"S0317167100048769_ref005","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.53.2.127"},{"key":"S0317167100048769_ref006","first-page":"782","article-title":"A controlled study of Tourette syndrome. IV Obsessions, compulsions and schizoid behaviours","volume":"41","author":"Comings","year":"1987","journal-title":"Am J Hum Genet"},{"key":"S0317167100048769_ref010","first-page":"701","article-title":"A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders and school problems","volume":"41","author":"Comings","year":"1987","journal-title":"Am J Hum Genet"},{"key":"S0317167100048769_ref007","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1176\/ajp.144.9.1166","article-title":"Clinical comparison of Tourette disorder and obsessive compulsive disorder","volume":"144","author":"Pitman","year":"1987","journal-title":"Am J Psychiatry"},{"key":"S0317167100048769_ref008","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1176\/ajp.149.9.1244","article-title":"Tics and Tourette\u2019s disorders: a 2 to 7 year follow-up of 54 obsessive-compulsive children","volume":"149","author":"Leonard","year":"1992","journal-title":"Am J Psychiatry"},{"key":"S0317167100048769_ref012","first-page":"761","article-title":"A controlled study of Tourette syndrome. III Phobias and panic attacks","volume":"41","author":"Comings","year":"1987","journal-title":"Am J Hum Genet"},{"key":"S0317167100048769_ref013","first-page":"804","article-title":"A controlled study of Tourette syndrome. V Depression and mania","volume":"41","author":"Comings","year":"1987","journal-title":"Am J Hum Genet"},{"key":"S0317167100048769_ref015","first-page":"206","article-title":"Tourette syndrome and neuropsychiatrie disorders: is there a relationship?","volume":"42","author":"Pauls","year":"1988","journal-title":"Am J Hum Genet"},{"key":"S0317167100048769_ref016","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.5.950"},{"key":"S0317167100048769_ref017","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.5.941"},{"key":"S0317167100048769_ref037","first-page":"77","article-title":"Neurobiological dissection of Tourette syndrome: a neurochemical focus on a human neuroanantomical model","volume":"35","author":"Bonnet","year":"1982","journal-title":"Adv Neurol"},{"key":"S0317167100048769_ref018","first-page":"311","article-title":"Neuropsychological assessment of children and adults with Tourette syndrome: a comparison of learning disabilities and schizophrenia","volume":"35","author":"Sutherland","year":"1982","journal-title":"Adv Neurol"},{"key":"S0317167100048769_ref019","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780350025002"},{"key":"S0317167100048769_ref021","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.652"},{"key":"S0317167100048769_ref022","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198403000-00002"},{"key":"S0317167100048769_ref026","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.10.1064"},{"key":"S0317167100048769_ref031","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.9.1269"},{"key":"S0317167100048769_ref036","first-page":"145","article-title":"Basal ganglia peptidergic staining in Tourette syndrome. A follow-up study","volume":"58","author":"Haber","year":"1992","journal-title":"Adv Neurol"},{"key":"S0317167100048769_ref039","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1176\/ajp.140.9.1183","article-title":"Treatment of Gilles de la Tourette syndrome with pimozide","volume":"140","author":"Shapiro","year":"1983","journal-title":"Am J Psychiatry"},{"key":"S0317167100048769_ref040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1176\/ajp.144.5.673","article-title":"ECG changes during haloperidol and pimozide treatment of Tourette's disorder","volume":"144","author":"Fulop","year":"1987","journal-title":"Am J Psychiatry"},{"key":"S0317167100048769_ref041","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.5.688"},{"key":"S0317167100048769_ref029","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870060221"},{"key":"S0317167100048769_ref042","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199002000-00008"},{"key":"S0317167100048769_ref043","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410180322"},{"key":"S0317167100048769_ref045","first-page":"391","article-title":"Clonidine in the treatment of Tourette's syndrome: a review of data","volume":"35","author":"Leckman","year":"1982","journal-title":"Adv Neurol"},{"key":"S0317167100048769_ref046","first-page":"583","article-title":"Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial","volume":"24","author":"Hunt","year":"1989","journal-title":"J Am Acad Child Psychiatr"},{"key":"S0317167100048769_ref047","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0193-953X(18)30260-0","article-title":"Pharmacotherapy of Tourette's syndrome and associated disorders","volume":"15","author":"Cohen","year":"1992","journal-title":"Psychiatr Clin North Am"},{"key":"S0317167100048769_ref027","first-page":"349","article-title":"A case of post-traumatic tic syndrome","volume":"35","author":"Fahn","year":"1982","journal-title":"Adv Neurol"},{"key":"S0317167100048769_ref035","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198812000-00012"},{"key":"S0317167100048769_ref038","first-page":"213","article-title":"Functional neuroanatomy of Tourettes: limbic motor interactions studied with FDG PET","volume":"58","author":"Stoetter","year":"1992","journal-title":"Adv Neurol"},{"key":"S0317167100048769_ref014","first-page":"742","article-title":"A controlled study of Tourette syndrome","volume":"41","author":"Comings","year":"1987","journal-title":"II Conduct Am J Hum Genet"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100048769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T15:25:15Z","timestamp":1557933915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100048769\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,2]]}},"alternative-id":["S0317167100048769"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100048769","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,2]]}}}